Related Experiment Video
Updated: Mar 17, 2026
A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
18F-DOPA PET/CT Physiological Distribution and Pitfalls: Experience in 215 Patients
Ferdinando F Calabria1, Agostino Chiaravalloti, Marielise L Jaffrain-Rea
1From the *Neuroimaging Research Unit, Institute of Molecular Bioimaging and Physiology, IBFM-CNR, Italian National Research Council, Catanzaro; †Department of Biomedicine and Prevention, University "Tor Vergata," Rome; ‡Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila; Departments of §Neuroendocrinology, and ∥Nuclear Medicine and Molecular Imaging, IRCCS Neuromed, Pozzilli, Isernia; ¶Radiation Oncology Unit, Sant' Andrea Hospital, University Sapienza, Rome, and IRCCS Neuromed, Pozzilli (IS), Italy; and **Department of Nuclear Medicine, Santa Maria Della Misericordia Hospital, Rovigo, Italy.
Purpose:
F-DOPA PET/CT is potentially helpful in the management of patients with low-grade brain tumors, movement disorders, and somatic neuroendocrine tumors. We describe the whole-body physiological distribution of F-DOPA uptake.
Patients And Methods:
We examined 215 patients with F-DOPA PET/CT. Among these, 161 had brain scans and 54 had whole-body scans.
Results:
Physiological distribution was negligible in the brain, with the exception of basal ganglia, whereas greatest activity was noted in the liver, pancreas, other exocrine glands, and the urinary system. Incidental tracer uptake sites were identified in 5.5% of patients. Some of these findings were due to inflammation, whereas in most cases, uptake was seen in benign tumors of the brain or in the endocrine or exocrine glands.
Conclusions:
F-DOPA uptake may be seen in inflammatory tissue or benign tumors. Correlations with history, physical examination, laboratory examination, CT, MRI, and histology are necessary for optimal diagnosis.
![PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F57243.jpg&w=3840&q=50)
Related Concept Videos
01:29Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET